In the last couple of weeks, we’ve explored what was said about Medicare Part D costs, beneficiary premiums and competition when the program was created – and at what has actually happened in the first 10 years of the program.
This week, we’re wrapping up our Part D then and now with a closer look at coverage.
Watch our video on how patients benefit from Part D coverage for more.
Allyson Funk Ally is a former senior director of public affairs at PhRMA focused on advocacy issues for the biopharmaceutical industry. Her expertise includes Medicare, Medicaid, 340B, health reform and more. Prior to PhRMA, her experience included leading health communications for a large membership organization, supporting public affairs clients and working for the governor of Louisiana.
Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004
Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
"1. Information Collection."